Eiger BioPharmaceuticals, Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization drugs for life-threatening, rare and ultra-rare diseases with high unmet medical needs and no approved therapies. The company was founded by David A. Cory and Glenn S. Jeffrey on November 6, 2008 and is headquartered in Palo Alto, CA.
Company profile
Website
CEO
David A. Cory
Employees
Incorporated
Location
Fiscal year end
SEC CIK
Latest filings (excl ownership)
D
$6M in debt / options / securities to be acquired, sold $6M, 4 investors
20 Nov 15
D/A
$14.6M in equity, sold $14.46M, 8 investors
24 Mar 15
D/A
$9.05M in equity, sold $8.74M, 8 investors
17 Feb 15
D/A
$7.26M in equity, sold $7.24M, 8 investors
20 Nov 14
D/A
$7.12M in equity, sold $6.91M, 8 investors
5 Sep 14
D/A
$5.87M in equity, sold $5.81M, 8 investors
11 Apr 14
D/A
$5.37M in equity, sold $5.31M, 8 investors
14 May 13
D/A
$5M in equity, sold $4.56M, 8 investors
29 Aug 12
D
$5M in equity, sold $3.55M, 4 investors
27 Apr 11
D/A
$8.3M in equity, sold $8.3M, 9 investors
20 Sep 10